|
Melphalan lmpurity 6
|
美法侖雜質(zhì)6
|
1951445-22-9
|
|
Melphalan lmpurity 3
|
美法侖雜質(zhì)3
|
896715-19-8
|
|
Melphalan lmpurity 7
|
美法侖雜質(zhì)7
|
|
|
Melphalan lmpurity 5
|
美法侖雜質(zhì)5
|
|
|
Mupirocin Impurity 6
|
莫匹羅星雜質(zhì)6
|
|
|
Ceftriaxone impurity 29(ene Isomer)
|
頭孢曲松雜質(zhì)29(烯異構(gòu)體)
|
|
|
Ticargrelor impurity 7
|
替格瑞洛雜質(zhì)7
|
2588537-76-0
|
|
Losartan system suitability
|
洛沙坦系統(tǒng)適用性CRS
|
|
|
Rifampicin impurities6
|
利福平雜質(zhì)6
|
|
|
Cefmetazole Impurity 21
|
頭孢美唑雜質(zhì)21
|
|
|
Rifampicin impurities5
|
利福平雜質(zhì)5
|
13292-53-0
|
|
Chlorpromazine impurity D
|
氯丙嗪雜質(zhì)D CRS(指定品牌EP Y0000479)
|
|
|
Betaxolol impurity a
|
倍他洛爾雜質(zhì)A（指定）
|
|
|
Isoproterenol Impurity 27
|
異丙腎上腺素雜質(zhì)27
|
|
|
Mupirocin EP Impurity G
|
莫匹羅星EP雜質(zhì)G
|
|
|
Mupirocin EP Impurity H
|
莫匹羅星EP雜質(zhì)H
|
|
|
Valsartan Impurity 3
|
纈沙坦雜質(zhì)3
|
|
|
Benidipine Impurity I
|
貝尼地平雜質(zhì)I
|
|
|
(2-hydroxy-2 - (3-hydroxyphenyl) ethyl) (methyl) amino) - 4-oxobuty-2-enoic acid
|
（2-羥基-2-（3-羥基苯基）乙基）（甲基）氨基）-4-氧代丁-2-烯酸
|
|
|
Bepotastine Impurity 3
|
貝他斯汀雜質(zhì)3
|
210095-66-2
|
|
Dydrogesterone Impurity 15
|
地屈孕酮雜質(zhì)15
|
|
|
N-(2-Quinoxaline)-sulfaquinoxalin.
|
N-（2-喹喔啉）-磺胺喹喔啉。
|
|
|
Articaine Impurity 17
|
阿替卡因雜質(zhì)17
|
2602451-78-3
|
|
Fosinopril related compound F
|
福辛普利相關(guān)化合物F（指定品牌USP?1283460）
|
|
|
Fosinopril related compound E
|
福辛普利相關(guān)化合物E（指定品牌USP?1283459）
|
|
|
Carbiramine related compound C
|
卡比沙明相關(guān)化合物C(指定品牌USP 1096032）
|
|
|
Fosinopril related compound B
|
福辛普利相關(guān)化合物B(指定品牌USP 1283426）
|
|
|
Ethyl cinnamate impurity 1
|
肉桂酸乙酯雜質(zhì)1
|
|
|
4-{4-fluoro-3-[(4-nitrosopiperazin-1-yl)carbonyl]benzyl}phthalazin-1(2H)-one
|
4-{4-氟-3-[（4-亞硝基哌嗪-1-基）羰基]芐基}酞嗪-1（2H）-酮
|
|
|
Febuxostat Impurity 32
|
非布索坦雜質(zhì)32
|
1805770-41-5
|
|
Ticagrelor system suitability for CRS
|
替卡格雷系統(tǒng)適用性CRS（指定）
|
|
|
Tranexamic acid impurity F
|
氨甲環(huán)酸雜質(zhì)F（指定品牌EP Y0002153）
|
|
|
Dydrogesterone Impurity 14
|
地屈孕酮雜質(zhì)14
|
|
|
Tranexamic Acid Impurity F CRS（designated brand EP Y0002154）
|
氨甲環(huán)酸雜質(zhì)F CRS（指定品牌EP Y0002154）
|
|
|
Siliconized microcrystalline cellulose
|
硅化微晶纖維素（指定USP貨號(hào)：1098399）
|
|
|
Nimesulide impurity D (control article)
|
尼美舒利雜質(zhì)D(對(duì)照品)（指定EP貨號(hào)：N0845008）
|
|
|
Phenylhexol impurity 4
|
苯海索雜質(zhì)4
|
|
|
Molnupiravir Impurity 21
|
莫那匹韋雜質(zhì)21
|
|
|
Fenoterol system suitability CRS
|
非諾特羅系統(tǒng)適用性CRS（指定品牌EP Y0002102）
|
|
|
8s-isopropyl-3β-hydroxytropanium bromide
|
8s-異丙基-3β-羥基托烷溴化物（指定BP貨號(hào)626）
|
|
|
Phenylhexol impurity 8
|
苯海索雜質(zhì)8
|
127865-20-7
|
|
Montelukast methanol impurities1
|
孟魯司特酮甲醇雜質(zhì)1（指定TLC貨號(hào)?M-3014）
|
|
|
Fluconazole triazole ethyl impurity
|
氟康唑三唑乙基雜質(zhì)(氟康唑雜質(zhì)25)
|
|
|
Bumetanide Impurity 23
|
布美他尼雜質(zhì)23
|
|
|
Bumetanide Impurity 24
|
布美他尼雜質(zhì)24
|
|
|
Methotrexate EP Impurity G
|
甲氨蝶呤EP雜質(zhì)G
|
2519848-42-9
|
|
Benhexol impurity 14
|
苯海索雜質(zhì)14
|
|
|
Ofloxacin impurity E
|
氧氟沙星雜質(zhì)E （貨號(hào)O0120050）
|
|
|
Methotrexate Impurity 26
|
甲氨蝶呤雜質(zhì)26
|
|
|
Estradiol valerate impurity 10
|
戊酸雌二醇雜質(zhì)10
|
|
|
Tranexamic acid impurity standard
|
氨甲環(huán)酸雜質(zhì)標(biāo)準(zhǔn)（指定品牌BP 貨號(hào)734）
|
|
|
Fluticasone Furoate Impurity 10
|
糠酸氟替卡松雜質(zhì)10
|
11111-34-5
|
|
Bumetanide Impurity 25
|
布美他尼雜質(zhì)25
|
|
|
Prednisolone Phosphate USP Impurity E
|
磷酸潑尼松龍USP雜質(zhì)E
|
|
|
Fluticasone Furoate Impurity 8
|
糠酸氟替卡松雜質(zhì)8
|
|
|
Tofatinib Impurity 40
|
托法替尼雜質(zhì)40
|
|
|
Cabergoline Impurity 24
|
卡麥角林雜質(zhì)24
|
591-87-7
|
|
Bumetanide Impurity 26
|
布美他尼雜質(zhì)26
|
|
|
Bumetanide Impurity 22
|
布美他尼雜質(zhì)22
|
|
|
Molnupiravir Impurity 16
|
莫那匹韋雜質(zhì)16
|
2346620-53-7
|
|
Lurasislone Impurity 18
|
魯拉西酮雜質(zhì)18
|
1807983-62-5
|
|
Molnupiravir Impurity 17
|
莫那匹韋雜質(zhì)17
|
|
|
Molnupiravir Impurity 19
|
莫那匹韋雜質(zhì)19
|
|
|
Famotidine Impurity 26
|
法莫替丁雜質(zhì)26
|
95853-46-6
|
|
Vitamin B2 impurity 3
|
維生素B2雜質(zhì)3
|
64480-68-8
|
|
Vitamin B2 impurity 1
|
維生素B2雜質(zhì)1
|
|
|
Drotaverine Impurity 23
|
屈他維林雜質(zhì)23
|
|
|
Drotaverine Impurity 26
|
屈他維林雜質(zhì)26
|
|
|
Drotaverine Impurity 25
|
屈他維林雜質(zhì)25
|
|
|
Drotaverine Impurity 28
|
屈他維林雜質(zhì)28(氮氧化物）
|
|
|
Drotaverine Impurity 27
|
屈他維林雜質(zhì)27
|
|
|
Avibatan genotoxic Impurity 2
|
阿維巴坦基因毒雜質(zhì)2
|
|
|
Avibatan genotoxic Impurity 1
|
阿維巴坦基因毒雜質(zhì)1
|
|
|
Timolol EP Impurity J
|
噻嗎洛爾EP雜質(zhì)J
|
|
|
Avibatan genotoxic Impurity 3
|
阿維巴坦基因毒雜質(zhì)3
|
|
|
Moxonidine adulterant(Impuriy) A
|
莫索尼定摻雜物(雜質(zhì)）（指定品牌EP Y0000222)
|
|
|
Gefitinib Impurity 69
|
吉非替尼雜質(zhì)69
|
|
|
Montelukast dicyclohexylamine
|
孟魯司特二環(huán)己胺（指定EP 貨號(hào)Y0001436）
|
|
|
Vigabatrin Impurity 18
|
氨己烯酸雜質(zhì)18
|
|
|
Lilalitine impurity 1
|
利拉利汀雜質(zhì)1
|
|
|
Omeprazole Related Compound F and G Mixture
|
奧美拉唑相關(guān)物質(zhì)F和G混合物 （貨號(hào)1478491）
|
|
|
Ibuprofen Impurity 69(mixture)
|
布洛芬雜質(zhì)69（混合物）
|
|
|
Ceftriaxone sodium impurity H
|
頭孢曲松鈉雜質(zhì)H
|
|
|
Salbutamol impurity B (designated brand BP cat. No: 852)
|
沙丁胺醇雜質(zhì)B(指定品牌BP 貨號(hào)：852)
|
|
|
Amphotericin B Impurity E
|
兩性霉素B雜質(zhì) E
|
|
|
Milbemycin EP impurities F
|
米爾貝霉素EP雜質(zhì)F
|
|
|
Fosfomycin tromethamine Impurity5(Disodium Salt)
|
磷霉素氨丁三醇雜質(zhì)5（二鈉鹽）
|
|
|
Ceftriaxone impurity 30 (olefin isomer disodium salt)
|
頭孢曲松雜質(zhì)30(烯異構(gòu)體二鈉鹽)
|
|
|
8s-isopropyl-3 β- Mm hydroxymethylammonium bromide
|
8s-異丙基-3β-羥基甲基溴化銨(指定BP 626）
|
|
|
1-nitroso-1H-benzotriazole
|
1-亞硝基-1H-苯并三唑
|
|
|
L-salbutamol impurity B
|
左旋沙丁胺醇雜質(zhì)B（指定BP 852）
|
|
|
Milbemycin EP impurities I
|
米爾貝霉素EP雜質(zhì)I
|
|
|
Fusidic Acid EP Impurity B
|
夫西地酸EP雜質(zhì)B
|
|
|
Macitentan Impurity 42
|
馬西替坦雜質(zhì)42
|
|
|
Milbemycin EP impurities D
|
米爾貝霉素EP雜質(zhì)D
|
|
|
Mupirocin Impurity 5
|
莫匹羅星雜質(zhì)5
|
|
|
Benhexol impurity 13
|
苯海索雜質(zhì)13
|
|
|
Fluticasone Furoate Impurity 9
|
糠酸氟替卡松雜質(zhì)9
|
|
|
Vilanterol Impurity 44
|
維蘭特羅雜質(zhì)44
|
24085-19-6
|
|
Articaine Impurity 20
|
阿替卡因雜質(zhì)20
|
47066-35-3
|